Saturday, October 31, 2026

USD/EUR Bullish Momentum With A 1% Rise In The Last 10 Sessions

ViaNews Editorial Team

October 8, 2024

USD/EUR Bullish Momentum With A 1% Rise In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.72% for the last 10 sessions. At 04:09 EST on Tuesday, 8 October, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 1.928% up from its 52-week low and 4.576% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was 0.38%, 0.06%, and 0.28%, respectively.

USD/EUR's highest amplitude of average volatility was 0.38% (last week), 0.30% (last month), and 0.28% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy price forecast: decisively breaches key resistance yet bearish signs persist. According to FXStreet on Monday, 7 October, "Yet bullish enthusiasm should be tempered by the possibility that USD/JPY may have formed a three-wave "abc" corrective pattern of the medium-term downtrend during July. "
  • According to FXStreet on Monday, 7 October, "Instead of trading around 142 at the start of the week, USD/JPY broke through 148 on Friday on the back of strong US employment data. "
  • According to FXStreet on Tuesday, 8 October, "This, in turn, might continue to offer some support to the USD/JPY pair and limit any further slide.", "Moreover, oscillators on the daily chart have been gaining positive traction and suggest that the path of least resistance for the USD/JPY pair is to the upside. "
  • Usd/jpy price forecast: snaps three-day rally, tumbles below 148.50. According to FXStreet on Monday, 7 October, "The USD/JPY failed to extend its uptrendafter piercing inside the Ichimoku Cloud (Kumo), which opened the door for further upside. ", "The USD/JPY retreated after rallying for three straight days, even though the US 10-year Treasury noy yield rose five basis points. "
  • Usd/jpy bounces off daily low, finds support near 148.00 amid bullish USD. According to FXStreet on Monday, 7 October, "Apart from this, a turnaround in the global risk sentiment, along with escalating geopolitical tensions in the Middle East, drives some haven flows towards the JPY and exerts some downward pressure on the USD/JPY pair. ", "This, in turn, will play a key role in influencing the near-term USD price dynamics and provide a fresh impetus to the USD/JPY pair. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com